Skip to main content

Electra Reports Q1 2026 Progress as Refinery Construction Accelerates

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today filed its operating results for the three months ended March 31, 2026, including the completion of several milestones in the construction of North America’s first battery-grade cobalt sulfate refinery. During the quarter, Electra advanced several refinery construction activities, approved a comprehensive construction budget and execution schedule, strengthened its commercial position through a strategic supply agreement with LG Energy Solution, and enhanced financial flexibility through expanded capital markets initiatives and government support. “During the quarter, we executed several construction activities supported by disciplined capital management while maintaining a strong liquidity...

Continue reading

Intuitive Machines Reports First Quarter 2026 Financial Results; Posts Record Quarterly Revenue, Gross Margin, and Positive Adjusted EBITDA along with Record Quarter-end Backlog of $1.1 Billion

HOUSTON, May 14, 2026 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology and infrastructure services company, today announced its financial results for the first quarter ended March 31, 2026. Intuitive Machines CEO Steve Altemus said, “Intuitive Machines continues to execute, grow, and win new business at record pace. Our acquisition of Lanteris has been immediately accretive with the combined entity already creating value.” HighlightsClosed $800 million acquisition of Lanteris Space Systems to become a vertically integrated next-generation space prime contractor for commercial, civil and national security space initiatives Signed definitive agreement in Q2 to acquire Goonhilly Earth Station and its COMSAT subsidiary to a create a space‑to‑ground data...

Continue reading

Merlin, Inc. Reports First Quarter 2026 Results

Company Introduces Condor, Merlin’s first product, bringing Merlin Pilot to large, multi-crew aircraft for civil and defense missions BOSTON, May 14, 2026 (GLOBE NEWSWIRE) — Merlin, Inc. (Nasdaq: MRLN), an aerospace and defense technology company building the operating system of record for autonomous flight, today announced operating and financial results for its first quarter ended March 31, 2026. This was the Company’s first quarterly report of operations as a public company following the close of its business combination with Inflection Point Acquisition Corp. IV on March 16, 2026. Business HighlightsAutomated takeoffs. On April 11 and April 21, Merlin executed its first fully automated takeoffs on fixed wing aircraft, one in the United States and one in New Zealand. Certification progression. Merlin’s civil certification...

Continue reading

NETSOL Technologies reports record quarterly revenue and 13% year-over-year growth in Q3 fiscal 2026

ENCINO, Calif., May 14, 2026 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a provider of AI-enabled solutions and services powering OEMs, dealerships and financial institutions to sell, finance and lease assets, reported its results for the third quarter of fiscal 2026 and nine months ended March 31, 2026.Total net revenues up 13.0% year-over-year to $19.8 million, the highest quarterly revenue in company history Recurring subscription and support revenues up 11.7% year-over-year to $8.8 million Annualized recurring revenue forecasted up 7% year-over-year to $35 million Gross margin expanded to 55.6% from 49.8% in the prior-year period Non-GAAP EBITDA grew by 48.2% year-over-year to $3.4 million, for a 17.2% EBITDA margin compared with 13.1% in the prior-year period Reaffirmed fiscal 2026 full-year revenue guidance...

Continue reading

American Shared Hospital Services Reports First Quarter 2026 Financial Results

15.9% Revenue Growth Driven by Direct Patient Services Expansion; Operating Performance Improves Year-Over-Year Gross Margins Increased 36.7% Year-Over-Year Adjusted EBITDA Increased 18.4% Year-Over-Year Volumes Continuing to Trend Higher into the Second Quarter Conference Call Scheduled for 12:00 PM ET Today SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, today announced financial results for the first quarter ended March 31, 2026. Key Financial HighlightsTotal revenue: $7.1 million, compared with $6.1 million in the first quarter of 2025, an increase of 15.9% Gross margin: Increased 36.7% to $1.3 million, or 18.2%, compared with...

Continue reading

Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance

First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year period First Quarter Net income was $41.7 million compared to $5.2 million for the prior year period Adjusted EBITDA for Q1 2026 was $84.4 million, a 25.2% increase over the prior year period Increased Full Year 2026 Revenue guidance to between $2.56 and $2.58 billion, updated from between $2.54 and $2.56 billionIncreased Full Year 2026 Adjusted EBITDA guidance to between $328 and $332 million, updated from between $318 and $322 millionATLANTA, May 14, 2026 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period ended April 4, 2026. Jeff Shaner, Chief Executive...

Continue reading

Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $26.2 million for the first quarter of 2026, reflecting strong launches in the US and most recently the UK Company achieves positive gross margin for the acute lymphoblastic leukemia (ALL) business Cost reduction initiative to drive gross profit margin improvement and path to profitability for the ALL business underway Obe-cel clinical development programs on track with trial enrollment ongoing in lupus nephritis, pediatric ALL and progressive multiple sclerosis (MS) Conference call to be held today at 8:30am EDT/1:30pm BST: conference call participants should pre-register using the link at the bottom of this press releaseLONDON and GAITHERSBURG, Md., May 14, 2026 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical...

Continue reading

Aya Gold & Silver Reports Q1-2026 Results with Record Revenue and Cash Flow

MONTREAL, May 14, 2026 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; NASDAQ: AYA) (“Aya” or the “Corporation”) today announced its financial and operational results for the first quarter ended March 31, 2026. All amounts are in U.S. dollars unless otherwise noted. Q1 2026 Highlights Financial HighlightsRevenue of $117M, up 247% year-over-year (“YoY”) and up 56% quarter-over-quarter (“QoQ”), driven by higher average net realized silver equivalent (“AgEq”) prices and more AgEq ounces sold, totaling 1.4M. Average net realized silver equivalent price of $82.22/oz, up 158% YoY and 41% QoQ. Net income of $49M (basic EPS of $0.34 and diluted EPS of $0.33), up 600% YoY from net income of $7M (basic and diluted EPS of $0.05) in Q1-2025 and from $18M (basic EPS of $0.13 and diluted EPS of...

Continue reading

Pelthos Therapeutics Announces First Quarter 2026 Financial Results

 ZELSUVMI® net product revenue grew 17% quarter over quarter from $9.1 million in the fourth quarter of 2025 to $10.7 million in the first quarter of 2026 7,884 ZELSUVMI units prescribed by 3,228 unique prescribers for the first quarter of 2026, with a 25% quarter over quarter increase in units dispensed Management will host a conference call today, May 14, 2026, at 8:30 a.m. ET DURHAM, N.C., May 14, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos,” “we” or the “Company”), today announced its financial results for the first quarter ended March 31, 2026, which can be found in the Financial Results section of the Company’s website at https://ir.pelthos.com/financial-info/financial-results. First...

Continue reading

Chicago Atlantic BDC, Inc. Reports First Quarter 2026 Financial Results

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026 HighlightsTotal gross investment income of $16.7 million Net investment income of $10.0 million, or $0.44 per weighted average share outstanding Total investment portfolio of $364.0 million at fair value, an increase of $30.7 million as compared to the prior quarter Net asset value (“NAV”) per share was $13.33 on March 31, 2026, a $0.03 increase as compared to the prior quarter Board of Directors declared a dividend of $0.34 per share for the quarter ending June 30, 2026, payable on July 10, 2026 to shareholders of record...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.